Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA4 | P22748 | 3/20 | 0.32 |
| ▸ | CA6 | P23280 | 3/20 | 0.32 |
| ▸ | CA5A | P35218 | 3/20 | 0.32 |
| ▸ | CA7 | P43166 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA3 | P07451 | 2/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CASP2 | P42575 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28281762 | 0.81 | — | — | |
| SCHEMBL22338145 | 0.78 | DNM1 (0.35) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL20380911 | 0.77 | — | — | |
| SCHEMBL24423962 | 0.76 | — | — | |
| SCHEMBL8626718 | 0.75 | NFKB1 (0.38) | NFKB1CHRM2CA12CA2CA4 | |
| SCHEMBL6294143 | 0.75 | NFKB1 (0.38) | NFKB1CHRM2CA12CA2CA4 | |
| SCHEMBL12977946 | 0.72 | — | — | |
| SCHEMBL4693105 | 0.71 | NFKB1 (0.33) | NFKB1TDP1CHRM2CA12CA2 | |
| SCHEMBL14910454 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL22575367 | 0.69 | TSHR (0.39) | CA12CA9CA1DNM1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3420016-B1 | BENZYLATED MANNICH BASE CURING AGENTS, COMPOSITIONS, AND METHODS | EVONIK OPERATIONS GMBH (DE) | 2025-01-15 | — | — | EP | disclosed |
| US-10669370-B2 | Benzylated mannich base curing agents, compositions, and methods | EVONIK OPERATIONS GMBH (DE) | 2020-06-02 | — | — | US | disclosed |
| CN-105102602-B | Preparaton, its as or for product dish washing detersive purposes and its preparation | 巴斯夫欧洲公司 | 2018-05-25 | — | — | CN | disclosed |
| US-20170240691-A1 | BENZYLATED MANNICH BASE CURING AGENTS, COMPOSITIONS, AND METHODS | EVONIK OPERATIONS GMBH (DE) | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10669370-B2 | Benzylated mannich base curing agents, compositions, and methods | H1-0, SRM, H1-2 | NFKB1 1305/4885TDP1 1658/4885CHRM2 1159/4885 |
| US-20170240691-A1 | BENZYLATED MANNICH BASE CURING AGENTS, COMPOSITIONS, AND METHODS | H1-0, SRM, H1-2 | NFKB1 1305/4885TDP1 1658/4885CHRM2 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.